Annual FCF
-$5.78 M
+$15.51 M+72.84%
December 31, 2023
Summary
- As of February 8, 2025, APYX annual free cash flow is -$5.78 million, with the most recent change of +$15.51 million (+72.84%) on December 31, 2023.
- During the last 3 years, APYX annual FCF has risen by +$10.87 million (+65.27%).
- APYX annual FCF is now -502.23% below its all-time high of $1.44 million, reached on December 31, 2004.
Performance
APYX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$4.59 M
+$25.00 K+0.54%
September 30, 2024
Summary
- As of February 8, 2025, APYX quarterly free cash flow is -$4.59 million, with the most recent change of +$25.00 thousand (+0.54%) on September 30, 2024.
- Over the past year, APYX quarterly FCF has increased by +$1.78 million (+27.96%).
- APYX quarterly FCF is now -230.41% below its all-time high of $3.52 million, reached on September 30, 2023.
Performance
APYX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$17.89 M
-$8.12 M-83.00%
September 30, 2024
Summary
- As of February 8, 2025, APYX TTM free cash flow is -$17.89 million, with the most recent change of -$8.12 million (-83.00%) on September 30, 2024.
- Over the past year, APYX TTM FCF has dropped by -$7.72 million (-75.98%).
- APYX TTM FCF is now -890.63% below its all-time high of $2.26 million, reached on September 30, 2011.
Performance
APYX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
APYX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +72.8% | +28.0% | -76.0% |
| 3 y3 years | +65.3% | -21.7% | -43.6% |
| 5 y5 years | +72.8% | +10.1% | +9.5% |
APYX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.8% | -230.4% | +28.0% | -209.4% | +16.0% |
| 5 y | 5-year | at high | +72.8% | -230.4% | +38.7% | -209.4% | +18.9% |
| alltime | all time | -502.2% | +72.8% | -230.4% | +74.8% | -890.6% | +48.1% |
Apyx Medical Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.59 M(-0.5%) | -$17.89 M(+83.0%) |
| Jun 2024 | - | -$4.62 M(-27.6%) | -$9.78 M(-3.8%) |
| Mar 2024 | - | -$6.38 M(+176.6%) | -$10.17 M(+75.8%) |
| Dec 2023 | -$5.78 M(-72.8%) | -$2.31 M(-165.4%) | -$5.78 M(-29.0%) |
| Sep 2023 | - | $3.52 M(-170.3%) | -$8.15 M(-52.7%) |
| Jun 2023 | - | -$5.01 M(+151.5%) | -$17.22 M(-6.8%) |
| Mar 2023 | - | -$1.99 M(-57.4%) | -$18.48 M(-13.2%) |
| Dec 2022 | -$21.29 M(+90.6%) | -$4.67 M(-15.8%) | -$21.29 M(+27.2%) |
| Sep 2022 | - | -$5.55 M(-11.6%) | -$16.74 M(+11.8%) |
| Jun 2022 | - | -$6.27 M(+30.8%) | -$14.96 M(+9.0%) |
| Mar 2022 | - | -$4.80 M(+3965.3%) | -$13.72 M(+22.9%) |
| Dec 2021 | -$11.17 M(-32.9%) | -$118.00 K(-96.9%) | -$11.17 M(-10.3%) |
| Sep 2021 | - | -$3.77 M(-25.0%) | -$12.46 M(+10.2%) |
| Jun 2021 | - | -$5.04 M(+124.4%) | -$11.31 M(-0.7%) |
| Mar 2021 | - | -$2.24 M(+59.7%) | -$11.39 M(-31.6%) |
| Dec 2020 | -$16.65 M(-15.8%) | -$1.41 M(-46.5%) | -$16.65 M(-11.1%) |
| Sep 2020 | - | -$2.63 M(-48.7%) | -$18.72 M(-11.7%) |
| Jun 2020 | - | -$5.12 M(-31.7%) | -$21.20 M(-3.9%) |
| Mar 2020 | - | -$7.50 M(+115.7%) | -$22.07 M(+11.6%) |
| Dec 2019 | -$19.78 M(-6.9%) | -$3.48 M(-31.9%) | -$19.78 M(-42.7%) |
| Sep 2019 | - | -$5.11 M(-14.7%) | -$34.51 M(+13.4%) |
| Jun 2019 | - | -$5.99 M(+15.0%) | -$30.42 M(+20.7%) |
| Mar 2019 | - | -$5.21 M(-71.4%) | -$25.20 M(+18.6%) |
| Dec 2018 | -$21.24 M(+390.9%) | -$18.21 M(+1676.2%) | -$21.24 M(+749.8%) |
| Sep 2018 | - | -$1.02 M(+33.8%) | -$2.50 M(+8.9%) |
| Jun 2018 | - | -$766.00 K(-38.6%) | -$2.30 M(-14.5%) |
| Mar 2018 | - | -$1.25 M(-331.8%) | -$2.69 M(-37.9%) |
| Dec 2017 | -$4.33 M(+38.6%) | $538.00 K(-165.5%) | -$4.33 M(-21.5%) |
| Sep 2017 | - | -$821.00 K(-29.0%) | -$5.51 M(+16.2%) |
| Jun 2017 | - | -$1.16 M(-60.0%) | -$4.75 M(+27.5%) |
| Mar 2017 | - | -$2.89 M(+345.8%) | -$3.72 M(+19.2%) |
| Dec 2016 | -$3.12 M(-49.7%) | -$648.00 K(+1100.0%) | -$3.12 M(-5.7%) |
| Sep 2016 | - | -$54.00 K(-59.4%) | -$3.31 M(-18.1%) |
| Jun 2016 | - | -$133.00 K(-94.2%) | -$4.04 M(-37.3%) |
| Mar 2016 | - | -$2.29 M(+173.0%) | -$6.45 M(+3.9%) |
| Dec 2015 | -$6.21 M(+492.8%) | -$838.00 K(+6.6%) | -$6.21 M(+13.2%) |
| Sep 2015 | - | -$786.00 K(-69.0%) | -$5.48 M(+32.0%) |
| Jun 2015 | - | -$2.54 M(+24.1%) | -$4.15 M(+111.0%) |
| Mar 2015 | - | -$2.04 M(+1709.7%) | -$1.97 M(+88.0%) |
| Dec 2014 | -$1.05 M(-66.5%) | -$113.00 K(-120.8%) | -$1.05 M(-57.3%) |
| Sep 2014 | - | $543.00 K(-253.8%) | -$2.45 M(-19.4%) |
| Jun 2014 | - | -$353.00 K(-68.6%) | -$3.04 M(-21.3%) |
| Mar 2014 | - | -$1.12 M(-26.0%) | -$3.86 M(+23.7%) |
| Dec 2013 | -$3.12 M(+431.3%) | -$1.52 M(+3200.0%) | -$3.12 M(+64.5%) |
| Sep 2013 | - | -$46.00 K(-96.1%) | -$1.90 M(-18.0%) |
| Jun 2013 | - | -$1.18 M(+206.3%) | -$2.31 M(+852.7%) |
| Mar 2013 | - | -$384.00 K(+31.1%) | -$243.00 K(-58.7%) |
| Dec 2012 | -$588.00 K(-143.4%) | -$293.00 K(-36.6%) | -$588.00 K(-6.1%) |
| Sep 2012 | - | -$462.00 K(-151.6%) | -$626.00 K(+44.2%) |
| Jun 2012 | - | $896.00 K(-222.9%) | -$434.00 K(+1105.6%) |
| Mar 2012 | - | -$729.00 K(+120.2%) | -$36.00 K(-102.7%) |
| Dec 2011 | $1.35 M | -$331.00 K(+22.6%) | $1.35 M(-40.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$270.00 K(-120.9%) | $2.26 M(+22.4%) |
| Jun 2011 | - | $1.29 M(+95.5%) | $1.85 M(-439.9%) |
| Mar 2011 | - | $662.00 K(+14.7%) | -$544.00 K(-25.2%) |
| Dec 2010 | -$727.00 K(-71.6%) | $577.00 K(-184.4%) | -$727.00 K(-64.6%) |
| Sep 2010 | - | -$684.00 K(-37.8%) | -$2.05 M(+35.1%) |
| Jun 2010 | - | -$1.10 M(-329.4%) | -$1.52 M(-3.9%) |
| Mar 2010 | - | $479.00 K(-163.9%) | -$1.58 M(-38.2%) |
| Dec 2009 | -$2.56 M(-32.2%) | -$750.10 K(+400.1%) | -$2.56 M(-17.8%) |
| Sep 2009 | - | -$150.00 K(-87.1%) | -$3.11 M(-43.4%) |
| Jun 2009 | - | -$1.16 M(+131.8%) | -$5.50 M(+29.5%) |
| Mar 2009 | - | -$500.80 K(-61.6%) | -$4.25 M(+12.4%) |
| Dec 2008 | -$3.78 M(-1100.1%) | -$1.30 M(-48.7%) | -$3.78 M(+141.1%) |
| Sep 2008 | - | -$2.54 M(-2824.0%) | -$1.57 M(-244.9%) |
| Jun 2008 | - | $93.20 K(-393.1%) | $1.08 M(+239.5%) |
| Mar 2008 | - | -$31.80 K(-103.5%) | $318.70 K(-15.7%) |
| Dec 2007 | $378.00 K(-26.1%) | $909.50 K(+718.6%) | $378.00 K(-148.7%) |
| Sep 2007 | - | $111.10 K(-116.6%) | -$775.50 K(+22.7%) |
| Jun 2007 | - | -$670.10 K(-2536.7%) | -$632.20 K(-408.8%) |
| Mar 2007 | - | $27.50 K(-111.3%) | $204.70 K(-60.0%) |
| Dec 2006 | $511.20 K(-146.5%) | -$244.00 K(-195.9%) | $511.30 K(-27.6%) |
| Sep 2006 | - | $254.40 K(+52.5%) | $705.90 K(+14.9%) |
| Jun 2006 | - | $166.80 K(-50.1%) | $614.60 K(-202.0%) |
| Mar 2006 | - | $334.10 K(-776.3%) | -$602.70 K(-45.2%) |
| Dec 2005 | -$1.10 M(-176.5%) | -$49.40 K(-130.3%) | -$1.10 M(+35.0%) |
| Sep 2005 | - | $163.10 K(-115.5%) | -$814.70 K(+631.3%) |
| Jun 2005 | - | -$1.05 M(+543.7%) | -$111.40 K(-108.6%) |
| Mar 2005 | - | -$163.20 K(-169.2%) | $1.29 M(-9.9%) |
| Dec 2004 | $1.44 M(+311.4%) | $235.90 K(-72.8%) | $1.44 M(+57.9%) |
| Sep 2004 | - | $866.40 K(+143.6%) | $910.20 K(+493.7%) |
| Jun 2004 | - | $355.60 K(-1843.1%) | $153.30 K(-69.9%) |
| Mar 2004 | - | -$20.40 K(-93.0%) | $509.70 K(+45.9%) |
| Dec 2003 | $349.40 K(-338.2%) | -$291.40 K(-366.1%) | $349.40 K(-60.3%) |
| Sep 2003 | - | $109.50 K(-84.6%) | $879.10 K(-5.7%) |
| Jun 2003 | - | $712.00 K(-494.0%) | $932.10 K(+4704.6%) |
| Mar 2003 | - | -$180.70 K(-175.8%) | $19.40 K(-113.2%) |
| Dec 2002 | -$146.70 K(-119.1%) | $238.30 K(+46.6%) | -$146.60 K(+477.2%) |
| Sep 2002 | - | $162.50 K(-181.0%) | -$25.40 K(-270.5%) |
| Jun 2002 | - | -$200.70 K(-42.1%) | $14.90 K(-95.2%) |
| Mar 2002 | - | -$346.70 K(-196.4%) | $312.40 K(-59.3%) |
| Dec 2001 | $767.80 K(+91.3%) | $359.50 K(+77.3%) | $767.80 K(+35.2%) |
| Sep 2001 | - | $202.80 K(+109.5%) | $567.80 K(+50.5%) |
| Jun 2001 | - | $96.80 K(-10.9%) | $377.20 K(+34.2%) |
| Mar 2001 | - | $108.70 K(-31.8%) | $281.00 K(-30.0%) |
| Dec 2000 | $401.40 K(-0.6%) | $159.50 K(+1207.4%) | $401.50 K(+65.9%) |
| Sep 2000 | - | $12.20 K(+1933.3%) | $242.00 K(+5.3%) |
| Jun 2000 | - | $600.00(-99.7%) | $229.80 K(+0.3%) |
| Mar 2000 | - | $229.20 K | $229.20 K |
| Dec 1999 | $404.00 K(-220.5%) | - | - |
| Dec 1998 | -$335.20 K(-6.0%) | - | - |
| Dec 1997 | -$356.50 K(+1031.7%) | - | - |
| Dec 1996 | -$31.50 K(-91.0%) | - | - |
| Dec 1995 | -$350.40 K | - | - |
FAQ
- What is Apyx Medical annual free cash flow?
- What is the all time high annual FCF for Apyx Medical?
- What is Apyx Medical annual FCF year-on-year change?
- What is Apyx Medical quarterly free cash flow?
- What is the all time high quarterly FCF for Apyx Medical?
- What is Apyx Medical quarterly FCF year-on-year change?
- What is Apyx Medical TTM free cash flow?
- What is the all time high TTM FCF for Apyx Medical?
- What is Apyx Medical TTM FCF year-on-year change?
What is Apyx Medical annual free cash flow?
The current annual FCF of APYX is -$5.78 M
What is the all time high annual FCF for Apyx Medical?
Apyx Medical all-time high annual free cash flow is $1.44 M
What is Apyx Medical annual FCF year-on-year change?
Over the past year, APYX annual free cash flow has changed by +$15.51 M (+72.84%)
What is Apyx Medical quarterly free cash flow?
The current quarterly FCF of APYX is -$4.59 M
What is the all time high quarterly FCF for Apyx Medical?
Apyx Medical all-time high quarterly free cash flow is $3.52 M
What is Apyx Medical quarterly FCF year-on-year change?
Over the past year, APYX quarterly free cash flow has changed by +$1.78 M (+27.96%)
What is Apyx Medical TTM free cash flow?
The current TTM FCF of APYX is -$17.89 M
What is the all time high TTM FCF for Apyx Medical?
Apyx Medical all-time high TTM free cash flow is $2.26 M
What is Apyx Medical TTM FCF year-on-year change?
Over the past year, APYX TTM free cash flow has changed by -$7.72 M (-75.98%)